ABP
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
11.43M
SVRA
Price
$2.19
Change
+$0.09 (+4.29%)
Updated
Jul 3 closing price
Capitalization
378.51M
32 days until earnings call
Interact to see
Advertisement

ABP vs SVRA

Header iconABP vs SVRA Comparison
Open Charts ABP vs SVRABanner chart's image
Abpro Holdings
Price$0.19
Change-$0.00 (-0.00%)
Volume$1.59M
Capitalization11.43M
Savara
Price$2.19
Change+$0.09 (+4.29%)
Volume$1.11M
Capitalization378.51M
ABP vs SVRA Comparison Chart in %
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. SVRA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Hold and SVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ABP: $0.19 vs. SVRA: $2.19)
Brand notoriety: ABP and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 11% vs. SVRA: 63%
Market capitalization -- ABP: $11.43M vs. SVRA: $378.51M
ABP [@Biotechnology] is valued at $11.43M. SVRA’s [@Biotechnology] market capitalization is $378.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, ABP is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 2 TA indicator(s) are bullish while SVRA’s TA Score has 5 bullish TA indicator(s).

  • ABP’s TA Score: 2 bullish, 4 bearish.
  • SVRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than ABP.

Price Growth

ABP (@Biotechnology) experienced а -15.70% price change this week, while SVRA (@Biotechnology) price change was -0.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

SVRA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($379M) has a higher market cap than ABP($11.4M). SVRA YTD gains are higher at: -28.664 vs. ABP (-89.497). ABP has higher annual earnings (EBITDA): -10.08M vs. SVRA (-108.24M). SVRA has more cash in the bank: 172M vs. ABP (1.26M). ABP has less debt than SVRA: ABP (3.25M) vs SVRA (29.6M). ABP has higher revenues than SVRA: ABP (183K) vs SVRA (0).
ABPSVRAABP / SVRA
Capitalization11.4M379M3%
EBITDA-10.08M-108.24M9%
Gain YTD-89.497-28.664312%
P/E RatioN/AN/A-
Revenue183K0-
Total Cash1.26M172M1%
Total Debt3.25M29.6M11%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPSVRA
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
47%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
21%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bearish Trend 4 days ago
15%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
49%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
72%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESLT444.328.75
+2.01%
Elbit Systems Ltd
DXC16.240.28
+1.75%
DXC Technology Company
KLXE1.95-0.02
-1.02%
KLX Energy Services Holdings
ECX2.16-0.04
-1.82%
ECARX Holdings
ROMA3.20-0.08
-2.44%
Roma Green Finance Limited

ABP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABP has been loosely correlated with XFOR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABP jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
-2.49%
XFOR - ABP
50%
Loosely correlated
-4.55%
NGNE - ABP
31%
Poorly correlated
+4.69%
FBIO - ABP
31%
Poorly correlated
+2.73%
SVRA - ABP
26%
Poorly correlated
+4.29%
QSI - ABP
26%
Poorly correlated
+8.08%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+4.29%
RCKT - SVRA
61%
Loosely correlated
+0.69%
PRTA - SVRA
46%
Loosely correlated
+1.82%
RVMD - SVRA
42%
Loosely correlated
+1.83%
ERAS - SVRA
41%
Loosely correlated
-0.69%
ORIC - SVRA
40%
Loosely correlated
+1.41%
More